Algen Biotechnologies
PrivateLast Round
Corporate Funding
Oct 6, 2025
Est. Valuation
$24M
Total Funding Raised
$9.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Algen Biotechnologies operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Corporate Funding round in October 2025.
Algen Biotechnologies is a biotechnology company that develops a precision therapeutics platform using CRISPR and AI to identify disease-driving gene networks for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Platform-as-a-Service
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Algen Biotechnologies Comparables
Compare Algen Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CoSyne Therapeutics | 83% | |
| Insitro | 83% | |
| Transcripta Bio | 81% |
For institutional investors. Book with your work email.
Algen Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Oct 6, 2025 | ||||
| VC Round | Nov 14, 2024 | ||||
| Grant | Sep 20, 2021 | ||||
| Seed | Aug 31, 2021 |
For institutional investors. Book with your work email.
Algen Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cota Capital | Seed |
| Sequoia Capital | Seed |
| Viking Global Investors | Seed |
| Draper Associates | Seed |
| Y Combinator | Seed |
| LifeSpan Vision Ventures | Seed, VC Round |
| Rebel Fund | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 25% QoQ, from 16 to 20 employees.
- Jul 26, 2026
Monthly visitors increased 36% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 23, 2026
Algen Bio creates AlgenBrain in 2018 as a genomics platform that identifies genetic drivers of disease progression and develops new therapies.
For institutional investors. Book with your work email.
Algen Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Algen Biotechnologies's valuation, stock price, and market status.
Is Algen Biotechnologies a public or private company?
Algen Biotechnologies is a private company.
What is the current stock price of Algen Biotechnologies?
Algen Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Algen Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Algen Biotechnologies worth (valuation)?
Algen Biotechnologies's valuation is estimated at $24.0M based on funding round data.
Can I buy Algen Biotechnologies stock?
Algen Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Algen Biotechnologies's last funding round?
Algen Biotechnologies's most recent funding round was Corporate Funding on October 6, 2025.
Who are the main investors in Algen Biotechnologies?
Key investors in Algen Biotechnologies include Cota Capital, Sequoia Capital, Viking Global Investors, Draper Associates, Y Combinator.
Will Algen Biotechnologies IPO soon?
No public IPO plans have been announced for Algen Biotechnologies.
How can I track Algen Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Algen Biotechnologies's shares on secondary markets.